Pharma Value

Pharma

Value

To be able to find the right path for the introduction of a medicine in Italy, it is necessary to explore and translate the map of the regulatory environment, identifying and analysing the expectations and reports of decision-makers.

We assist those who turn to us in understanding and obtaining a fair price and reimbursement for a medicine. Finding a common ground, by appropriately mediating between Company profit, patient needs and the limited resources of the National Health Service, is a victory for all interest groups involved.

Through the years, we have learnt that the reality of things is more complex than whatever had been planned.

Even when everything is well-prepared and strategies corresponding to the value of the medicine, in accordance with the regulatory objectives of the agencies, and accommodating to drug governance guidelines, are proposed, the pathway to the authorisation of a medicine may well progress differently than expected. Not to mention any external variables that could slow down, if not hinder, the access of a medicine to the market.

Integrated skills are needed to help with navigation

Though quite detailed, the map we have provided cannot define the complexity of the terrain. Our experience comes to the aid when it is not clear.

Notes

AIFA GUIDELINES - Our comments

1 October 2020

Il 30 settembre 2020 abbiamo inviato all’indirizzo email dedicato di AIFA i nostri commenti alle “Linee guida per la compilazione del Dossier ...

Scenario analysis

WE LIVE IN INTERESTING TIMES - MARKET ACCESS

17 July 2020

Il contesto italiano del mercato farmaceutico, da quello normativo a quello regolatorio, è sempre stato uno scenario fortemente mutevole, sia per i ...

Mapping

LEA Commission

3 July 2020

È stata costituita con DM del 5/5/2020 la nuova Commissione nazionale per l’aggiornamento dei Livelli Essenziali di Assistenza (LEA). La commissione dura ...